Superbugs! Clinical Controversies in the Management of Multiple-Drug Resistant Bacteria

Sunday, December 2, 2012
1:45 PM – 3:15 PM

Planned in cooperation with the ASHP New Practitioners Forum
Activity #: 204-000-12-308-L01P
Level of Content: Advanced
1.50 Contact Hours / Application-based
Program Chair: Rachel Chambers, PharmD

Learning Objectives:

• Apply recent literature on colistin safety and dosing to the care of an individual patient.
• Interpret the literature comparing carbapenems and non-carbapenem beta-lactams for the treatment of ESBL producing enterobacteriaceae.
• Given an individual patient case, develop a rational, cost effective antimicrobial regimen for the management of methicillin resistant Staphylococcus aureus (MRSA) bacteremia.